The temples that are slowly disappearing.

It is the hairline, at both sides.

Not the sharp recession you associate with male pattern baldness.

Something softer than that, and in its way harder to describe.

A gradual thinning of the hair at the temples. The line is less defined. The skin is visible in a way that is subtle but changes the face.

You notice it most when your hair is pulled back.

A bun. A ponytail. Brushing it off your face to wash it.

The moment where the hairline is suddenly right there, visible, unmissable.

You have started wearing your hair differently. Not dramatically differently — you would not describe it as hiding anything. But you think about it now, where you didn’t before.

You have probably changed your shampoo. You may have tried something specifically for the temples — a serum, a spray — and watched it produce nothing you could call a result.

Here is what the follicle research actually says is happening at the temple.

The temples are specifically difficult because they are visible in a way the crown is not.

The crown requires a particular angle to see. The temples are there every time you look in the mirror straight on.

Every time you wash your face. Every time you pull your hair back for any reason.

What changes is the face. The shape of it. The frame of it.

You have looked at your face your entire adult life, and the hairline was part of that — part of where the face begins and ends.

When that line moves, the face in the mirror is the same face with something slightly different about it.

You cannot always name what you are looking at. You just know it is not quite how it was.

The people around you almost certainly cannot tell. You can tell.

The question is what produced this — and whether the follicles at the temples can still be reached.

It is not one problem. It is three problems running at the same time.

This is why the standard treatments produce partial results.

Each of them addresses one part of the cascade. The other two parts continue unchecked.

Problem 1: DHT sensitivity at the follicle

Oestrogen protects hair follicles. It keeps them resistant to DHT — the androgen that triggers miniaturisation.

When oestrogen falls in perimenopause, that protection falls with it.

DHT starts binding more readily to receptors in the follicle’s dermal papilla. Each growth cycle produces a slightly finer, slightly shorter hair. Over months and years, this compounds.

The follicle is not dead. It has been suppressed. This distinction is what determines what is still possible.

Problem 2: Microcirculation changes at the scalp

Oestrogen also maintains blood vessel tone in the scalp.

As levels fall, scalp microcirculation decreases. The follicle receives less nutrient and oxygen delivery with each cycle.

A follicle that was receiving everything it needed at 40 is receiving measurably less at 48. Even in women eating well. Even in women otherwise healthy.

Problem 3: Growth-phase dysregulation

The hair follicle cycles between growth (anagen) and rest (telogen).

The hormonal shift shortens the anagen phase and lengthens telogen. More follicles rest at any given time. More hairs fall out at once. The hair that grows back comes back thinner.

The three problems amplify each other. DHT sensitivity increases resting phase length. Poor circulation reduces the signal quality that restarts growth. And follicles in extended rest become harder to re-activate over time.

The treatments that fail for this kind of hair loss

Most products address one part of the problem.

Perimenopause-driven hair loss has three parts. That’s why most products produce partial results at best — and no result at worst.

Here is what the research says about the most commonly tried approaches:

The conclusion from the research is not that these treatments are useless. It is that none of them addresses all three cascade points simultaneously.

Which is precisely what the six-peptide formulation does — and why the research on combination approaches is considerably more compelling than any single-mechanism study.

What Cuivre contains — and why each ingredient is there

The six peptides in Cuivre are not a proprietary blend with a marketing name.

Each one was selected because it addresses a specific, documented failure point in the perimenopause hair loss cascade.

No filler. No carrier ingredient dressed up as active. Six actives. Six mechanisms.

The formula is applied to a dry or towel-dry scalp and left on. It is not rinsed away. The peptides remain in contact with the follicle for hours — long enough to penetrate and signal.

This is the delivery problem that makes shampoo-based approaches physiologically impossible to work at a follicle level. Contact time is not a minor consideration. It is the mechanism.

The realistic timeline

Hair biology is slow. The growth cycle is 84 days. No product changes that.

What changes, if the signal reaches the follicle, is what happens inside that cycle.